CN114026646A - 用于评估肿瘤分数的系统和方法 - Google Patents

用于评估肿瘤分数的系统和方法 Download PDF

Info

Publication number
CN114026646A
CN114026646A CN202080037877.1A CN202080037877A CN114026646A CN 114026646 A CN114026646 A CN 114026646A CN 202080037877 A CN202080037877 A CN 202080037877A CN 114026646 A CN114026646 A CN 114026646A
Authority
CN
China
Prior art keywords
tumor
sample
allele
coverage
locus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080037877.1A
Other languages
English (en)
Chinese (zh)
Inventor
伯纳德·芬德勒
杰森·D·休斯
史蒂文·罗尔斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foundation Medical Co
Original Assignee
Foundation Medical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foundation Medical Co filed Critical Foundation Medical Co
Publication of CN114026646A publication Critical patent/CN114026646A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202080037877.1A 2019-05-20 2020-05-20 用于评估肿瘤分数的系统和方法 Pending CN114026646A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962850474P 2019-05-20 2019-05-20
US62/850,474 2019-05-20
PCT/US2020/033821 WO2020236941A1 (en) 2019-05-20 2020-05-20 Systems and methods for evaluating tumor fraction

Publications (1)

Publication Number Publication Date
CN114026646A true CN114026646A (zh) 2022-02-08

Family

ID=73458622

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080037877.1A Pending CN114026646A (zh) 2019-05-20 2020-05-20 用于评估肿瘤分数的系统和方法

Country Status (11)

Country Link
US (2) US20220243279A1 (enExample)
EP (1) EP3973530A4 (enExample)
JP (1) JP7702360B2 (enExample)
KR (1) KR20220011140A (enExample)
CN (1) CN114026646A (enExample)
AU (2) AU2020279752A1 (enExample)
BR (1) BR112021022879A2 (enExample)
CA (1) CA3140066A1 (enExample)
IL (1) IL288182A (enExample)
SG (1) SG11202111947PA (enExample)
WO (1) WO2020236941A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114530200A (zh) * 2022-03-18 2022-05-24 北京阅微基因技术股份有限公司 基于计算snp熵值的混合样本鉴定方法
CN121305088A (zh) * 2025-12-09 2026-01-09 中国人民解放军空军军医大学 迁移学习驱动的颅内肿瘤影像数据全自动分割方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014262481A1 (en) 2013-05-10 2015-11-26 Foundation Medicine, Inc. Analysis of genetic variants
EP4256075A4 (en) * 2020-12-03 2024-10-23 Foundation Medicine, Inc. TREE MODEL FOR SELECTING TREATMENTS AND DETERMINING EXPECTED TREATMENT OUTCOMES
US20230227897A1 (en) * 2020-12-16 2023-07-20 Seedna Inc. Method for calculating the fidelity of the signal of polymorphic genetic loci
CN113025716A (zh) * 2021-03-02 2021-06-25 北京大学第一医院 一种用于人肿瘤分级的基因组合及其用途
EP4359569A4 (en) * 2021-06-22 2025-02-26 Foundation Medicine, Inc. Systems and methods for evaluating tumor fraction
US20250095775A1 (en) * 2021-07-23 2025-03-20 Foundation Medicine, Inc. Methods for determining variant frequency and monitoring disease progression
CN118103916A (zh) * 2021-10-08 2024-05-28 基金会医学公司 用于检测和去除针对拷贝数改变调用的污染的方法和系统
EP4430614A4 (en) * 2021-11-12 2025-12-17 Found Medicine Inc Circulating tumor DNA fraction and uses thereof
EP4437122A4 (en) * 2021-11-23 2025-08-06 Found Medicine Inc METHODS AND SYSTEMS FOR REPORTING CLINICALLY ACTIVE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES
WO2023107869A1 (en) 2021-12-08 2023-06-15 Foundation Medicine, Inc. Methods and systems for highlighting clinical information in diagnostic reports
WO2024015973A1 (en) * 2022-07-15 2024-01-18 Foundation Medicine, Inc. Methods and systems for determining circulating tumor dna fraction in a patient sample
US20260141981A1 (en) * 2022-10-14 2026-05-21 Foundation Medicine, Inc. Methods and systems for performing genomic variant calls based on identified off-target sequence reads
US20260193351A1 (en) * 2022-11-27 2026-07-09 The University Of Chicago Methods for treating cancer with immunotherapy
EP4631049A4 (en) * 2022-12-09 2026-02-18 Found Medicine Inc METHODS AND SYSTEMS FOR DETERMINING THE CLONALITY OF SOMATIC SHORT VARIANTS
CN121219428A (zh) * 2023-05-15 2025-12-26 基金会医学公司 用于评定液体活检样品中循环肿瘤dna分数的方法和系统
WO2024238750A2 (en) * 2023-05-17 2024-11-21 Foundation Medicine, Inc. Clonal hematopoiesis burden as a biomarker for immune checkpoint inhibitor response
WO2025054202A1 (en) 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
AU2025208175A1 (en) 2024-01-12 2026-06-25 Sana Biotechnology, Inc. Safety switches to control in vitro and in vivo proliferation of cell therapy products
WO2026102094A1 (en) * 2024-11-07 2026-05-15 Foundation Medicine, Inc. Combined chemistry and computational corrections for methyl-bias
WO2026165523A1 (en) 2025-01-31 2026-08-06 Foundation Medicine, Inc. Methods and systems for detecting howell-jolly bodies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014014497A1 (en) * 2012-07-20 2014-01-23 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome
CN104662168A (zh) * 2012-06-21 2015-05-27 香港中文大学 用于癌症检测的血浆dna突变分析
WO2015164432A1 (en) * 2014-04-21 2015-10-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CN109196359A (zh) * 2016-02-29 2019-01-11 基础医疗股份有限公司 用于评估肿瘤突变负荷的方法和系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110301854A1 (en) * 2010-06-08 2011-12-08 Curry Bo U Method of Determining Allele-Specific Copy Number of a SNP
RU2717641C2 (ru) * 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
DK3256605T3 (da) * 2015-02-10 2022-03-14 Univ Hong Kong Chinese Påvisning af mutationer til cancerscreening og føtal analyse
HK1255446A1 (zh) * 2015-09-25 2019-08-16 Canexia Health Inc. 分子质量保证方法在测序中的应用
WO2018236911A1 (en) * 2017-06-20 2018-12-27 Illumina, Inc. Methods and systems for decomposition and quantification of dna mixtures from multiple contributors of known or unknown genotypes
AU2018304458B2 (en) * 2017-07-21 2021-12-09 Foundation Medicine, Inc. Therapeutic and diagnostic methods for cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104662168A (zh) * 2012-06-21 2015-05-27 香港中文大学 用于癌症检测的血浆dna突变分析
WO2014014497A1 (en) * 2012-07-20 2014-01-23 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome
WO2015164432A1 (en) * 2014-04-21 2015-10-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CN109196359A (zh) * 2016-02-29 2019-01-11 基础医疗股份有限公司 用于评估肿瘤突变负荷的方法和系统

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114530200A (zh) * 2022-03-18 2022-05-24 北京阅微基因技术股份有限公司 基于计算snp熵值的混合样本鉴定方法
CN121305088A (zh) * 2025-12-09 2026-01-09 中国人民解放军空军军医大学 迁移学习驱动的颅内肿瘤影像数据全自动分割方法
CN121305088B (zh) * 2025-12-09 2026-03-17 中国人民解放军空军军医大学 迁移学习驱动的颅内肿瘤影像数据全自动分割方法

Also Published As

Publication number Publication date
SG11202111947PA (en) 2021-12-30
BR112021022879A2 (pt) 2022-03-22
JP7702360B2 (ja) 2025-07-03
KR20220011140A (ko) 2022-01-27
EP3973530A4 (en) 2023-08-02
US20250259709A1 (en) 2025-08-14
JP2022533137A (ja) 2022-07-21
CA3140066A1 (en) 2020-11-26
US20220243279A1 (en) 2022-08-04
EP3973530A1 (en) 2022-03-30
AU2025271452A1 (en) 2026-01-29
WO2020236941A1 (en) 2020-11-26
IL288182A (en) 2022-01-01
AU2020279752A1 (en) 2022-01-06

Similar Documents

Publication Publication Date Title
JP7702360B2 (ja) 腫瘍分率を評価するためのシステムおよび方法
JP7145907B2 (ja) 疾患細胞不均一性を示す疾患の検出および処置、ならびに通信試験結果のためのシステムおよび方法
JP2024112843A (ja) ゲノム変化を評価するための組成物および方法
CN109196359B (zh) 用于评估肿瘤突变负荷的方法和系统
JP2022532897A (ja) マルチラベルがん分類のためのシステムおよび方法
CN121354685A (zh) 无细胞dna中的微卫星不稳定性检测
WO2022271159A1 (en) Systems and methods for evaluating tumor fraction
US20230162815A1 (en) Methods and systems for accurate genotyping of repeat polymorphisms
CN116583904A (zh) 用于癌症分类的样品确认
EP4427226A1 (en) System and method for identifying copy number alterations
CN118103525A (zh) 用于自动调用拷贝数改变的方法和系统
EP4600963A1 (en) Methods and systems for determining blood tumor mutational burden in a liquid biopsy assay
US20240412812A1 (en) Methods and systems for detecting and removing contamination for copy number alteration calling
US20240420799A1 (en) Methods and systems for predicting the reliability of somatic/germline calls for variant sequences
HK40075645A (en) Method and system for assessing tumor mutation load
Cradic Next Generation Sequencing: Applications for the Clinic
HK40002957B (en) Methods and systems for evaluating tumor mutational burden
HK40002957A (en) Methods and systems for evaluating tumor mutational burden

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination